Innovation at Interphex - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
Innovation at Interphex
A preview of some product enhancements and launches for Interphex 2008, the large trade show being held Mar. 26–28 in Philadelphia.


Pharmaceutical Technology
Volume 3, Issue 32

The "Series DH3" differential pressure controller provides a 4–20 mA process output, two single-pole double-throw relays with adjustable dead bands, and a large, bright backlit LCD display. The DH3 offers simplified programming via a menu key that enables the user to select: security level; set point or set point and alarm operation; auto or manual alarm reset; English or metric engineering units; pressure, velocity or flow operation, K-factor for use with various Pitot tubes and flow sensors, circular or rectangular duct size for volumetric flow operation plus many more. The sensing element can detect low differential pressures down to 0.1 in. w.c. Ranges up to 100-in. w.c. as well as bidirectional ranges are also available. These features make the DH3 "Digihelic" differential pressure controller the ideal instrument for monitoring pressures in various rooms, zones, and ducts in factories, laboratories or buildings.

Smith: We will be introducing a new positive pump specifically for the pharmaceutical industry. Our "Johnson Top Wing" pump uses innovative materials, an extremely simple, clean internal design and several gearbox innovations to address industry concerns about efficiency, reliability, and the ability to clean-in-place and steam-in-place.

Water purification and disinfection

Fournier: For pharmaceutical water, we are introducing a single-skid design for producing USP-purified water. This design will be available in several configurations that would meet the needs of most applications.

For filtration, we are introducing a tangential-flow hollow-fiber filter that can be used in processing various solutions in pharmaceutical manufacturing. The most common use would be to filter fermentation broths in biotech processing. The advantage is faster processing times with higher yields.

For disinfectants, we are introducing a "Mini Fog" device for dry fogging small enclosures such as hoods in laboratories. This will replace a very labor-intensive and inefficient process of manually cleaning these areas with a process that is fast and very effective.

Personal protection equipment

Rowe: In 2008, Bullard will be launching and promoting our sterilized respirators that are FDA-validated to 10-6 sterility-assurance levels.

For a related story, see "Innovation in Equipment and Machinery" from the March 2008 issue.


ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters
Subscribe:Check the box next to each newsletter you wish to subscribe for:
| Weekly
| Monthly
| Monthly | Weekly
 Name:
 E-mail:

Survey
At this month's AAPS Annual Meeting & Exposition, several graduate students were awarded as young innovators. What are your thoughts on innovation and the next generation?
We need more young innovators and more students enrolling in pharma science programs
Our industry has just the right mix of young and old to keep innovation going
Age is irrelevant when it comes to innovation
We need more young innovators and more students enrolling in pharma science programs
25%
Our industry has just the right mix of young and old to keep innovation going
16%
Age is irrelevant when it comes to innovation
59%
View Results
Jim MillerOutsourcing OutlookJim Miller Facing Reality
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advancing Chiral Chemistry in API Synthesis
Faiz kermaniSpotlightFaiz Kermani Demographic time bomb
Rx-360 Takes on Europe, Talks to PharmTech in Podcast Series
Sanctions, Not Barcodes
Vaccines Finding Their Way in Novel Applications
Genzyme’s Friday the 13th
DTCA: Beneficial or Harmful?
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here